ResultsIQ

ResultsIQ › Latest results › Jyothy Labs Limited

Jyothy Labs Limited Q3 FY26 earnings call summary

NSE: JYOTHYLAB · BSE: 532926

Earnings call of 9 Feb 2026, summarised by AI from the filing.

Jyothy Labs Q3 FY26 revenue ₹740 cr with 5.1% value growth; gross margin 46.5% and likely to remain subdued over the next couple of quarters.

Key takeaways

  1. Q3 revenue ₹740 cr, value growth 5.1% and volume growth 7.2% year-on-year.
  2. Gross margin guidance Gross margin likely to remain subdued over the next couple of quarters at the minimum.
  3. Dishwash price cuts Portfolio-level downward pricing revision of 8% to 9% in Dishwash category.
  4. Fabric Care growth 9.2% value growth driven primarily by volume; liquid detergents high double-digit volume growth.
  5. Margin pressure Gross margin under pressure from MRP cuts and elevated input prices of LABSA, SLES.

Original filing on BSE

Jyothy Labs Limited Q1 FY27 results

As filed: Revenue ₹773 cr (+3% year on year), EBITDA ₹64.7 cr (−48% year on year), PAT ₹47.6 cr (−51% year on year), EBITDA margin 8.4% (−828 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹717 cr (+8% year on year), EBITDA ₹96.8 cr (−15% year on year), PAT ₹67.5 cr (−12% year on year), EBITDA margin 13.5% (−363 bps). Score 38 of 100, Below trend. Revenue growth was above the company's own trend; EBITDA growth was well below it; profit growth was below it. EBITDA margin fell 363 bps year on year. Revenue fell 3% from last quarter. Share price after the results: −24.7% in 30 days (Nifty 500: −1.0%).
  • Q3 FY26: Revenue ₹740 cr (+5% year on year), EBITDA ₹111 cr (−4% year on year), PAT ₹81.1 cr (−7% year on year), EBITDA margin 15.0% (−137 bps). Score 40 of 100, In line with trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 137 bps year on year. Profit fell 8% from last quarter. Share price after the results: −3.1% in 30 days (Nifty 500: −5.9%).
  • Q2 FY26: Revenue ₹736 cr (0% year on year), EBITDA ₹118 cr (−14% year on year), PAT ₹88.0 cr (−16% year on year), EBITDA margin 16.0% (−279 bps). Score 21 of 100, Below trend. Revenue growth was below the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 279 bps year on year. Profit fell 9% from last quarter. Share price after the results: −8.0% in 29 days (Nifty 500: +0.7%).
  • Q1 FY26: Revenue ₹751 cr (+1% year on year), EBITDA ₹125 cr (−6% year on year), PAT ₹97.0 cr (−5% year on year), EBITDA margin 16.6% (−130 bps). Score 26 of 100, Below trend. Revenue and profit growth were below the company's own trend; EBITDA growth was well below it. EBITDA margin fell 130 bps year on year. Share price after the results: +1.0% in 30 days (Nifty 500: 0.0%).
  • Q4 FY25: Revenue ₹667 cr (+1% year on year), EBITDA ₹113 cr (+5% year on year), PAT ₹76.0 cr (−3% year on year), EBITDA margin 16.9% (+58 bps). Score 32 of 100, Below trend. Revenue, EBITDA and profit growth were below the company's own trend. EBITDA margin rose 58 bps year on year. Revenue fell 5% from last quarter. Share price after the results: −5.0% in 30 days (Nifty 500: +7.7%).
  • Q3 FY25: Revenue ₹704 cr (+4% year on year), EBITDA ₹115 cr (−3% year on year), PAT ₹87.0 cr (−4% year on year), EBITDA margin 16.3% (−107 bps). Score 26 of 100, Below trend. Revenue growth was below the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 107 bps year on year. Revenue fell 4% from last quarter.
  • Q2 FY25: Revenue ₹734 cr (0% year on year), EBITDA ₹138 cr (+2% year on year), PAT ₹105 cr (+1% year on year), EBITDA margin 18.8% (+36 bps). Score 34 of 100, Below trend. EBITDA margin rose 36 bps year on year. Not enough history for a trend yet: scored on growth alone.

Past price moves after results do not indicate future moves. Not a recommendation.

Jyothy Labs Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.